About InnoVein
InnoVein is a company based in San Carlos (United States) founded in 2015. InnoVein has raised $13.41 million across 6 funding rounds from investors including National Science Foundation and Y Combinator. The company has 9 employees as of December 31, 2022. InnoVein operates in a competitive market with competitors including SPS Health, MDpanel, Segulah Medical Acceleration, Vyne Dental and HealthCare Appraisers, among others.
- Headquarter San Carlos, United States
- Employees 9 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Innovein, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.41 M (USD)
in 6 rounds
-
Latest Funding Round
$2.55 M (USD), Seed
Feb 06, 2023
-
Investors
National Science Foundation
& 1 more
-
Employee Count
9
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of InnoVein
InnoVein has successfully raised a total of $13.41M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $2.55 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in InnoVein
InnoVein has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include National Science Foundation and Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for InnoVein
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by InnoVein
Investment portfolio details for InnoVein
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - InnoVein
Detailed financials for InnoVein
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Innovein Comparisons
Peer comparison for InnoVein
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of InnoVein
InnoVein operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SPS Health, MDpanel, Segulah Medical Acceleration, Vyne Dental and HealthCare Appraisers, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of pharmacy management solutions
|
|
| Locked | Locked | Locked |
Provider of medical evaluations services
|
|
| Locked | Locked | Locked |
Invests in medical devices, diagnostics, and healthtech for growth stages in Europe.
|
|
| Locked | Locked | Locked |
Provider of solutions for dental practices to claims processing, attachments, and secure messaging
|
|
| Locked | Locked | Locked |
Healthcare valuation, transaction advisory, and litigation support services are offered.
|
Detailed competitors of InnoVein
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Innovein
Complete news archive for InnoVein
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about InnoVein
InnoVein was founded in 2015 and raised its 1st funding round 1 year after it was founded.
InnoVein is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.
David Hovda is the current CEO of InnoVein.
InnoVein is a funded company, having raised a total of $13.41M across 6 funding rounds to date.
As of Dec 31, 2022, the latest employee count at InnoVein is 9.
InnoVein was founded in 2015 and is headquartered in San Carlos, United States. Focus is placed on the development of medical devices targeted at valve replacement procedures within the healthcare sector. Operations center on innovative solutions for cardiovascular treatments, with leadership provided by CEO David Hovda. The companys domain, innovein.com, supports its activities in advancing medical technology.
InnoVein's top competitors include Vyne Dental, MDpanel and Med-Eval.
InnoVein has 2 investors. Key investors include National Science Foundation, and Y Combinator.